On-skin glucose-biosensing and on-demand insulin-zinc hexamers delivery using microneedles for syringe-free diabetes management
- 20 May 2020
- journal article
- research article
- Published by Elsevier BV in Chemical Engineering Journal
- Vol. 398, 125536
- https://doi.org/10.1016/j.cej.2020.125536
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology, Chang Gung Memorial Hospital
- National Health Research Institutes, Taiwan (MOST106-2628-E-110-001-MY3, MOST106-2628-B-110-001-MY4, CMRPG3J1262, CMRPG3J0092, NHRI-EX109-10502NI)
This publication has 37 references indexed in Scilit:
- Glucose-Responsive Microgels Integrated with Enzyme Nanocapsules for Closed-Loop Insulin DeliveryACS Nano, 2013
- Injectable Nano-Network for Glucose-Mediated Insulin DeliveryACS Nano, 2013
- Artificial pancreas: the bridge to a cure for type 1 diabetesEuropean Diabetes Nursing, 2012
- Prediabetes: a high-risk state for diabetes developmentThe Lancet, 2012
- Materials for Diabetes TherapeuticsAdvanced Healthcare Materials, 2012
- Organization of Glucose-Responsive Systems and Their PropertiesChemical Reviews, 2011
- Nanotechnology‐Enabled Closed Loop Insulin Delivery Device: In Vitro and In Vivo Evaluation of Glucose‐Regulated Insulin Release for Diabetes ControlAdvanced Functional Materials, 2010
- The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 DiabetesAnnals of Internal Medicine, 2007
- Insulins today and beyondThe Lancet, 2001
- Pharmacokinetic actions of exendin‐4 in the rat: Comparison with glucagon‐like peptide‐1Drug Development Research, 2001